Publicaciones en las que colabora con LUIS MIGUEL ORTEGA MORA (44)

2024

  1. An Early Treatment With BKI-1748 Exhibits Full Protection Against Abortion and Congenital Infection in Sheep Experimentally Infected With Toxoplasma gondii

    Journal of Infectious Diseases, Vol. 229, Núm. 2, pp. 558-566

2021

  1. A short-term treatment with BKI-1294 does not protect foetuses from sheep experimentally infected with Neospora caninum tachyzoites during pregnancy

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 17, pp. 176-185

  2. Identification of molecular biomarkers associated with disease progression in the testis of bulls infected with Besnoitia besnoiti

    Veterinary research, Vol. 52, Núm. 1, pp. 106

2020

  1. A model for chronic bovine besnoitiosis: Parasite stage and inoculation route are key factors

    Transboundary and Emerging Diseases, Vol. 67, Núm. 1, pp. 234-249

  2. Added value of IgM detection and low avidity index as markers of acute bovine besnoitiosis

    Veterinary Parasitology, Vol. 277

  3. Histological findings in experimentally infected male calves with chronic besnoitiosis

    Veterinary Parasitology, Vol. 281

  4. Isolation and genetic characterization of Neospora caninum from naturally infected sheep

    Veterinary Parasitology, Vol. 280

  5. Prevalence of intestinal parasite infections in stray and farm dogs from Spain

    Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria, Vol. 29, Núm. 3, pp. e014920

  6. Vascular wall injury and inflammation are key pathogenic mechanisms responsible for early testicular degeneration during acute besnoitiosis in bulls

    Parasites & vectors, Vol. 13, Núm. 1, pp. 113

2019

  1. Early Neospora caninum infection dynamics in cattle after inoculation at mid-gestation with high (Nc-Spain7)- or low (Nc-Spain1H)-virulence isolates

    Veterinary Research, Vol. 50, Núm. 1

  2. Prevalence of bovine trichomonosis and associated risk factors in bulls from Spanish beef herds

    Theriogenology, Vol. 128, pp. 116-121

  3. The route of Besnoitia besnoiti tachyzoites inoculation does not influence the clinical outcome of the infection in calves

    Veterinary Parasitology, Vol. 267, pp. 21-25

  4. Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 7

  5. Virulence in Mice of a Toxoplasma gondii Type II Isolate Does Not Correlate With the Outcome of Experimental Infection in Pregnant Sheep

    Frontiers in Cellular and Infection Microbiology, Vol. 9, Núm. JAN

2018

  1. An Ibero-American inter-laboratory trial to evaluate serological tests for the detection of anti-Neospora caninum antibodies in cattle

    Tropical Animal Health and Production, Vol. 50, Núm. 1, pp. 75-84

  2. Effect of parasite dose and host age on the infection with Besnoitia besnoiti tachyzoites in cattle

    Transboundary and Emerging Diseases, Vol. 65, Núm. 6, pp. 1979-1990

  3. Influence of dose and route of administration on the outcome of infection with the virulent Neospora caninum isolate Nc-Spain7 in pregnant sheep at mid-gestation

    Veterinary Research, Vol. 49, Núm. 1

  4. Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 8, Núm. 1, pp. 112-124

2017

  1. Bovine chronic besnoitiosis in a calf: Characterization of a novel B. besnoiti isolate from an unusual case report

    Veterinary Parasitology, Vol. 247, pp. 10-18

  2. Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2334-2341